InvestLog
RGEN logo

RGEN

Repligen CorporationNASDAQHealthcare
$117.78-0.46%ClosedMarket Cap: $6.63B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-23HC Wainwright & Co.—Buy—
2026-02-25Evercore ISI Group—Outperform—
2026-02-25Barclays—Overweight—
2026-02-25UBS—Buy—
2026-02-25Wells Fargo—Overweight—
2026-01-16UBS—Buy—
2025-12-15Wells Fargo—Overweight—
2025-12-15Barclays—Overweight—
2025-10-29Barclays—Overweight—
2025-10-29Canaccord Genuity—Hold—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$2.53$947.8M11
Sun Dec 31$3.31$1.09B5
Mon Dec 31$4.47$1.28B1
Tue Dec 31$5.68$1.47B1